AF Symposium 2024 — Dr Emile Daoud (Chief Medical Officer of S4 Medical) joins us to talk about the data from the EASY AF study (NCT04659213). 

This randomized, controlled study investigated the use of an esophageal deviating device versus no device. The study showed that the use of the esophageal deviating device (S4 Medical) resulted in a significantly lower rate of ablation-related esophageal lesions compared to the control group (5.7% vs. 35.4%).

1. What are some of the unmet needs in AF?
2. Can you tell us about the esolution device?
3. What was the study design, eligibility criteria, and outcome measures?
4. What are the key findings?
5. What are the take-home messages for practice? What are the next steps?

Videography: David Ramsey, William Cadden, Oliver Miles
Editorial: Brad Wilson

Recorded on-site at AF Symposium 2024, Boston.